Sales decline 36.59% to Rs 116.90 crore
Net Loss of Sterling Biotech reported to Rs 88.48 crore in the quarter ended June 2015 as against net loss of Rs 103.77 crore during the previous quarter ended June 2014. Sales declined 36.59% to Rs 116.90 crore in the quarter ended June 2015 as against Rs 184.36 crore during the previous quarter ended June 2014. ParticularsQuarter EndedJun. 2015Jun. 2014% Var.Sales116.90184.36 -37 OPM %18.2724.12 -PBDT-60.81-83.05 27 PBT-130.98-147.11 11 NP-88.48-103.77 15Powered by Capital Market - Live News